No LabelTirzepatide 10 Mg
| Quantity | Discount | Price |
|---|---|---|
| 3–5 | 10% | $54,00 |
| 6–9 | 15% | $51,00 |
| 10–100 | 20% | $48,00 |
Specifications
- Brand: No-Label HGH, Peptides & SARMs
- Substance: Tirzepatide
- Product Form: Powder
- Dosage: 10 Mg
How To Use
Laboratory Preparation & Research Dosing Protocols
Disclaimer: The following information is for educational and laboratory reference only. This product is strictly for in-vitro and in-vivo research and is not intended for human consumption or therapeutic use.
This vial contains 10 mg (10,000 mcg) of lyophilized Tirzepatide powder. Careful handling and precision measurement are critical for accurate data collection.
Reconstitution Guide
For standard research concentration, reconstitute the 10 mg vial with 1 ml or 2 ml of Bacteriostatic Water. (Using 2 ml provides greater measuring precision).
- Preparation: Slowly inject the water against the glass wall of the vial.
- Dissolution: Swirl gently until clear. Do not shake, as the peptide structure is sensitive to mechanical stress.
- Measurement Reference (Using 2 ml dilution):
- 4 Units (0.04 ml) = 200 mcg
- 10 Units (0.10 ml) = 500 mcg
- 20 Units (0.20 ml) = 1,000 mcg (1 mg)
Storage Specifications
- Unmixed (Lyophilized): Store in a cool, dry place. For long-term preservation, store at -20°C.
- Mixed (Reconstituted): Must be refrigerated (2°C to 8°C). Use within 14-21 days for maximum analytical integrity.
Experience Level Usage Guide
Beginner
Baseline Metabolic Secretagogue Model
Reference dosing for initial studies investigating the modulation of basal metabolic rate and early tolerance.
- Test Subject Dosage: 200 mcg to 500 mcg per administration.
- Frequency: Administered as a single dose once weekly.
- Research Aim: Assessment of subject tolerance and appetite regulation markers.
Intermediate
Advanced Thermogenic Evaluation Model
Standard dosage for evaluating the long-term impact of dual-pathway agonism on weight loss.
- Test Subject Dosage: 500 mcg to 1,000 mcg (1 mg) per week (can be split into smaller sub-doses, e.g., 500 mcg twice a week).
- Frequency: Administered on a weekly basis, or split into two smaller administrations.
- Observation Period: 4 to 8 weeks for longitudinal data collection.
Advanced
The Metabolic Synergy Stack
Advanced protocol investigating the synergy between fat oxidation and direct tissue remodeling.
- The Stack: Tirzepatide (500 mcg weekly) + BPC-157 (250 mcg daily).
- Scientific Rationale: Investigates the combined impact of profound energy expenditure/fat loss (Tirzepatide) alongside systemic soft-tissue/cytoprotective repair (BPC-157).
- Frequency: Combined weekly and daily schedule according to study objectives.
Shipping Details
Detailed Description
What Is No Label Tirzepatide 10 mg?
No Label Tirzepatide 10 mg is an innovative, dual-action incretin mimetic that serves as a combined Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptor agonist. In the scientific community, it is highly researched for its ability to activate both pathways simultaneously, resulting in a dual-synergistic effect on metabolic regulation and fat utilization. This 10 mg lyophilized preparation is an ideal instrument for high-precision USA domestic research facilities investigating weight management, glycemic balance, and lipid clearance pathways.
If your research goals involve exploring advanced glycemic balance or complex metabolic dysfunctions, you can buy peptides of this analytical grade through our Fat Loss Peptides category.
Important: No Label Tirzepatide 10 mg is strictly for laboratory research and is not intended for human consumption or therapeutic use.
No Label Tirzepatide 10 mg: Technical Profile
| Scientific Parameter | Details for No Label Tirzepatide |
|---|---|
| Peptide Category | Dual GIP and GLP-1 Receptor Agonist |
| Vial Concentration | 10 mg Lyophilized Powder |
| Sequence Focus | Glycemic Index Regulation & Lipid Clearance |
Research Benefits of No Label Tirzepatide 10 mg
In controlled laboratory settings, it is valued for its multi-layered metabolic effects. Key research benefits include:
- Dual-Receptor Synergy: Studying the compound’s combined action on GIP and GLP-1 receptors to optimize lipid clearance and insulin sensitivity.
- Appetite and Craving Suppression: Investigating its action on the hypothalamus and brainstem, influencing the centers that control hunger and gastric emptying.
- Improved Glycemic Control: Researching the peptide’s ability to blunt sharp post-meal glucose spikes and improve overall metabolic efficiency.
- Synergy with Metabolic Agents: Exploring how Peptidesline’s Tirzepatide, when combined with localized secretagogues, creates a multi-faceted approach to body recomposition.
How Does No Label Tirzepatide 10 mg Work?
The mechanism of Tirzepatide relies on its ability to mimic both GIP and GLP-1 hormones. It acts on the brain to increase feelings of satiety and decrease food intake, while working peripherally to stimulate glucose-dependent insulin secretion and lower glucagon levels. Because Peptidesline provides vacuum-sealed, analytical-grade No Label products, researchers can reliably track these physiological shifts with high experimental accuracy.
Potential Side Effects in Research Models
Researchers utilizing Tirzepatide must monitor for physiological responses associated with its administration:
- Gastrointestinal Distress: Potential observed effects include temporary nausea or vomiting during initial exposure as gastric emptying slows.
- Localized Sensitivity: Possible mild redness, warmth, or irritation at the injection site.
- Metabolic Variation: Fluctuations in baseline glucose markers that require close monitoring in test subjects.
- Cardiovascular Changes: Possible observed increases in resting heart rate in high-concentration assays.
Tirzepatide vs. Alternative Metabolic Compounds
| Research Agent | Targeted Action | Main Research Strength |
|---|---|---|
| Semaglutide | GLP-1 Receptor Agonist | Single-pathway appetite and glycemic control. |
| Retatrutide | Triple GIP/GLP-1/Glucagon Agonist | Advanced fat oxidation and metabolic expenditure. |
| HGH Frag 176-191 | Modified GH Fragment | Direct localized lipolysis without appetite suppression. |
| Tirzepatide 10 mg | Dual GIP / GLP-1 Agonist | Ideal balance of glycemic regulation and lipid clearance. |
Buy No Label Tirzepatide 10 mg Online
When conducting critical lipid metabolism or weight-loss assays, Peptidesline is your reliable source for batch-certified compounds. Our Tirzepatide is vacuum-sealed and HPLC-verified for 100% integrity.
- Express USA Delivery: Fast shipping to your research facility in 4-7 business days.
- Secure Checkout: Simple payment options via Zelle or Venmo.
- 10% Crypto Discount: Unlock a 10% discount on Tirzepatide 10 mg by paying with Bitcoin or USDT.
- Click here for Payment Options
FAQ
The addition of GIP receptor agonism works together with the GLP-1 pathway, resulting in improved fat clearance and fewer gastrointestinal side effects during experimental testing.
The 10 mg format provides an extended supply for assays, ensuring researchers on Peptidesline maintain batch consistency across a longer experimental timeline.
It supports glucose-dependent insulin secretion, meaning it enhances insulin levels only when blood glucose is elevated, preventing hypoglycemia.
In laboratory studies, Tirzepatide has an extended half-life of approximately 5 days, allowing for less frequent administration protocols.
Tirzepatide should be reconstituted gently and protected from physical agitation to maintain the structural integrity of the dual-chain molecule.
Semaglutide only targets the GLP-1 receptor. Tirzepatide is a dual agonist targeting both GLP-1 and GIP receptors, often leading to more significant fat loss results.
